Subsequent studies have also confirmed that CCL19 can be used as an adjuvant for immunization with intradermal gene guns in a Her2/neu mouse tumor model, with enhanced vaccine efficacy (Nguyen-Hoai et al., 2012). The gene discussed is CCL19; the disease is neoplasm.